These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10905235)

  • 41. Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate.
    Wraight JM; Smith AD; Cowan JO; Flannery EM; Herbison GP; Taylor DR
    Respirology; 2004 Jun; 9(2):215-21. PubMed ID: 15182272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can oral beta2 agonists cause heart failure?
    Jenne JW
    Lancet; 1998 Oct; 352(9134):1081-2. PubMed ID: 9798578
    [No Abstract]   [Full Text] [Related]  

  • 43. Is there a problem with inhaled long-acting beta-adrenergic agonists?
    Nelson HS
    J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular collapse in a 77-year-old-woman with an asthma exacerbation following bronchodilator treatment.
    Meyer MF; Hopkins WE; Kaminsky DA
    Chest; 2003 Sep; 124(3):1160-3. PubMed ID: 12970051
    [No Abstract]   [Full Text] [Related]  

  • 45. Paradoxical response to levalbuterol.
    Broski SE; Amundson DE
    J Am Osteopath Assoc; 2008 Apr; 108(4):211-3. PubMed ID: 18443029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 47. Media mishandle medical news.
    Meyer CR
    Minn Med; 1992 Jun; 75(6):7. PubMed ID: 1353859
    [No Abstract]   [Full Text] [Related]  

  • 48. Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.
    Fishwick D; Bradshaw L; Macdonald C; Beasley R; Gash D; Bengtsson T; Bondesson E; Borgström L
    Am J Respir Crit Care Med; 2001 Feb; 163(2):474-7. PubMed ID: 11179125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (2). Why beta-agonists should not be used regularly.
    Page C; Costello J
    Respir Med; 1992 Nov; 86(6):477-9. PubMed ID: 1361680
    [No Abstract]   [Full Text] [Related]  

  • 50. Laryngospasm and paradoxical bronchoconstriction after repeated doses of beta 2-agonists containing edetate disodium.
    Mutlu GM; Moonjelly E; Chan L; Olopade CO
    Mayo Clin Proc; 2000 Mar; 75(3):285-7. PubMed ID: 10725956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lactic acidosis in asthma: report of two cases and review of the literature.
    Prakash S; Mehta S
    Can Respir J; 2002; 9(3):203-8. PubMed ID: 12068341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (1). Beta-agonists can be used safely and beneficially in asthma.
    Twentyman OP; Higenbottam TW
    Respir Med; 1992 Nov; 86(6):471-6. PubMed ID: 1361679
    [No Abstract]   [Full Text] [Related]  

  • 53. Deleterious effects of inhaled beta-agonists: short-acting and long-acting agents differ.
    Sears MR
    Chest; 2001 May; 119(5):1297-9. PubMed ID: 11348928
    [No Abstract]   [Full Text] [Related]  

  • 54. [Lactic acidosis induced by inhaling high doses of salbutamol].
    Gómez Bustos MD; García Ron A; Ibarra de la Rosa I; Pérez Navero JL
    An Pediatr (Barc); 2008 Dec; 69(6):586-7. PubMed ID: 19128781
    [No Abstract]   [Full Text] [Related]  

  • 55. Revisiting interactions between hypoxaemia and beta2 agonists in asthma.
    Lipworth BJ
    Thorax; 2001 Jul; 56(7):506-7. PubMed ID: 11413346
    [No Abstract]   [Full Text] [Related]  

  • 56. Dose reduction of beta-agonists in asthma.
    Sears MR
    Lancet; 1991 Nov; 338(8778):1331-2. PubMed ID: 1682705
    [No Abstract]   [Full Text] [Related]  

  • 57. Second line treatment for severe acute childhood asthma.
    South M
    Thorax; 2003 Apr; 58(4):284-5. PubMed ID: 12668785
    [No Abstract]   [Full Text] [Related]  

  • 58. Dosage and delivery of nebulised beta agonists in hospital.
    Stainforth JN; Lewis RA; Tattersfield AE
    Thorax; 1983 Oct; 38(10):751-4. PubMed ID: 6139891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-agonist use as an indicator of change in asthma control during pregnancy.
    Valet RS; Dupont WD; Mitchel EF; Hartert TV
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):352-3. PubMed ID: 19441610
    [No Abstract]   [Full Text] [Related]  

  • 60. Management of beta-agonist overuse: why and how?
    Taylor DR; Hannah D
    J Allergy Clin Immunol; 2008 Oct; 122(4):836-838. PubMed ID: 18760453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.